Bad science and bogus treatments: latest news

Bad science and bogus treatments resources

  • Myths and facts

    There's a lot of misunderstanding and HIV and AIDS. Not everything you hear about HIV and AIDS is true.Some of the myths are about how...

    From: The basics

    Information level Level 1

Bad science and bogus treatments news from aidsmap

More news

Bad science and bogus treatments news selected from other sources

  • Pakistan: Factory making fake Hepatitis C drug raided

    Assisted by the Federal Investigation Authority (FIA), personnel of the Drug Regulatory Authority of Pakistan (DRAP) raided one of the local industries in Islamabad’s Kahuta industrial area here Saturday, leading to the discovery of unlawful manufacturing of Sofasbuvir tablets, which are used for the treatment of Hepatitis C, and Everlong tablets, the registration of which has long been withdrawn.

    04 March 2015 | The International News
  • Health News Review analysis of Bloomberg's coverage of PrEP

    This story takes as a given that the drug being discussed is 92% effective for preventing HIV infections. Exploring that statistic would have uncovered some fundamental concerns about the value of this treatment approach.

    24 February 2015 | Health News Review
  • Health News Review analysis of Reuters' coverage of new hepatitis C drugs

    We wish that more stories would bring some skeptical thinking to their coverage of expensive new hepatitis C treatments. The emphasis on short-term effects obscures the lack of long-term data about benefits.

    13 February 2015 | Health News Review
  • Aids denialism in London – It is really 2015?

    The latest in a 30-year long effort to mislead the public was an event in London earlier this month. The Frontline Club – a charitable foundation supporting journalism around the world – chose to lend its venue and name to the promotion of a 16-year old, long discredited book by Joan Shelton questioning the proven link between HIV and AIDS.

    09 February 2015 | Incidence 0
  • Déjà Vu – Claims of HIV Cures and Re-Treading Old Ground

    A few days ago while in Abuja, I was surprised to hear the news presenter announce that a Federal High Court had “lifted the ban” on Dr Abalaka’s “vaccine” against HIV. I was struck by a number of things – an abiding discomfort at the quality of reporting on science and health matters in the Nigerian media; a sense of guilt that, in failing to tell our stories, younger Nigerians are at risk of repeating missteps of the past; and a fear that many, misled by the news item, may put their lives at risk.

    28 January 2015 | Nigeria Health Watch
  • Why scientific AIDS explanations struggle in townships

    HIV/AIDS educators often seem to enjoy raising an eyebrow at outlandish beliefs over the disease. But in doing so they fail to realise that the joke is on them – these ideas continue to hold sway despite their best efforts.

    26 January 2015 | Africa Check
  • Preventing bad reporting on health research

    Academics should be made accountable for exaggerations in press releases about their own work

    10 December 2014 | BMJ
  • Is HIV Weakening Over Time?

    There has been an explosion of media stories positing that the virulence of HIV is decreasing and that the virus is evolving into a “milder form." But the study prompting the coverage relies primarily on laboratory measurements of HIV replication capacity, despite the fact that a prior publication—by several of the same authors—reports that results from this test do not predict the rate of CD4 T cell decline over time.

    03 December 2014 | TAG
  • Pat Robertson, Medical Expert: 'The Towels Might Have AIDS'

    On a recent episode of The 700 Club, television's premier destination for religious bigotry since 1966, Robertson advised a viewer that while the chances of contracting Ebola in Kenya are slim, travelers should beware of AIDS-ridden towels. What? Yes.

    31 October 2014 | Poz
  • Are antimicrobial condoms the new frontier against STIs? Not quite…

    Australian biotech company Starpharma has announced the imminent launch of a condom coated with an antimicrobial chemical known as VivaGel. While it might be marketed as a great leap forward for preventing sexually transmitted infections (STIs), it’s unlikely to offer any more protection than your average condom.

    14 October 2014 | The Conversation
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.